Aprepitant Oral Suspension and Moxetumomab Pasudotox-tdfk
Determining the interaction of Aprepitant Oral Suspension and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Oral Suspension-Moxetumomab pasudotox-tdfk Intravenous
- Aprepitant Oral Suspension-Moxifloxacin
- Aprepitant Oral Suspension-Moxifloxacin (Systemic)
- Aprepitant Oral Suspension-Moxifloxacin Hydrochloride
- Aprepitant Oral Suspension-Moxifloxacin Injection
- Aprepitant Oral Suspension-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Aprepitant/Fosaprepitant Dimeglumine
- Moxetumomab Pasudotox-tdfk-Apresazide
- Moxetumomab Pasudotox-tdfk-Apresoline
- Moxetumomab Pasudotox-tdfk-Apresoline Injection
- Moxetumomab Pasudotox-tdfk-Apri
- Moxetumomab Pasudotox-tdfk-Apriso